The Biohaven Pharmaceutical Holding Company Ltd. announced today its clinical trial collaboration with the Alzheimer’s Disease Cooperative Study (ADCS). Post navigationPreviousPrevious post:NYU’s EXERT Study Principal Investigator Martin Sadowski, MD, PhD wants to be able to write a prescription for exerciseNextNext post:STAT reports on the hunt for a new Alzheimer’s gene!